ROYALE THERAPEUTICS LIMITED - LONDON
Company Profile | Company Filings |
Overview
ROYALE THERAPEUTICS LIMITED is a Private Limited Company from LONDON UNITED KINGDOM and has the status: Dissolved - no longer trading.
ROYALE THERAPEUTICS LIMITED was incorporated 7 years ago on 05/01/2017 and has the registered number: 10548266. The accounts status is TOTAL EXEMPTION FULL.
ROYALE THERAPEUTICS LIMITED was incorporated 7 years ago on 05/01/2017 and has the registered number: 10548266. The accounts status is TOTAL EXEMPTION FULL.
ROYALE THERAPEUTICS LIMITED - LONDON
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 1 | 31/01/2018 |
Registered Office
2ND FLOOR REGIS HOUSE
LONDON
EC4R 9AN
UNITED KINGDOM
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
N/A | N/A |
Map
UNITED KINGDOM
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
PENELOPE SHIHAB | Dec 1973 | Jordanian | Director | 2017-01-15 | CURRENT |
PROFESSOR CHRISTOPHER ROBIN LOWE | Oct 1945 | British | Director | 2017-01-24 | CURRENT |
JOHN AIKEN MCKINLEY | Jun 1954 | British | Director | 2017-01-24 | CURRENT |
HS SECRETARIAL LIMITED | Corporate Secretary | 2017-01-05 | CURRENT | ||
MR JAMES PATRICK LAWRENCE | Oct 1961 | Director | 2017-01-05 UNTIL 2017-01-15 | RESIGNED |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Penelope Shihab | 2017-01-05 | 12/1973 | Amman |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
Royale Therapeutics Limited - Accounts to registrar (filleted) - small 18.2 | 2018-11-21 | 31-01-2018 | £3,272 Cash £-232,538 equity |